NCT06769607 Evaluation of a Novel Auto-Adjusting Positive Airway Pressure Algorithm for the Treatment of Obstructive Sleep Apnea Clinical Study
| NCT ID | NCT06769607 |
| Status | Recruiting |
| Phase | — |
| Sponsor | ResMed |
| Condition | Obstructive Sleep Apnea |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-04-10 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2025-04-10 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to assess the effectiveness of an investigational algorithm in the treatment of obstructive sleep apnea.
Eligibility Criteria
Inclusion Criteria: * Participants willing to give written informed consent. * Participants who can read and comprehend English. * Participants who ≥ 18 years of age * Participants who have been using a ResMed AirSense 10 or 11 device. * Participants currently using AutoSet (APAP) mode. * Participants being established on PAP therapy for the treatment of OSA for approximately \>3 months. * Participants who can participate in the study for up to 8 weeks. Exclusion Criteria: * Participants using Bilevel flow generators. * Participants using CPAP, AutoSet for Her * Participants who are or may be pregnant. * Participants with a preexisting lung disease/ condition that would predispose them to pneumothorax (for example: COPD, lung cancer; fibrosis of the lungs; recent (\< 2years) case of pneumonia or lung infection; lung injury. * Participants believed to be unsuitable for inclusion by the researcher. * Participants who are currently enrolled in other medical clinical studies
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06769607 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Obstructive Sleep Apnea. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06769607 currently recruiting?
Yes, NCT06769607 is actively recruiting participants. Contact the research team at sumudu.herath@resmed.com.au for enrollment information.
Where is the NCT06769607 trial being conducted?
This trial is being conducted at Bella Vista, Australia.
Who is sponsoring the NCT06769607 clinical trial?
NCT06769607 is sponsored by ResMed. The trial plans to enroll 80 participants.